Tag: phase 3

August 13, 2019

Novan Completes Phase 3 Enrollment for Molluscum Pivotal Program

Novan (NASDAQ:NOVN) has announced it has completed enrollment of its ongoing B-SIMPLE Phase 3 pivotal trials of SB206 to treat...
August 8, 2019

Geron Begins Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes

Geron (NASDAQ:GERN) has announced it has started patient screening and enrollment of its Phase 3 clinical trials to evaluate its...
June 3, 2019

Aeglea BioTherapeutics Doses First Patient in Phase 3 Trial of Pegzilarginase in Arginase 1 Deficiency

Aeglea BioTherapeutics (NASDAQ:AGLE) has announced the first patient in its Phase 3 PEACE trial has been dosed. As quoted in...
April 5, 2019

Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy

Gilead Sciences (NASDAQ:GILD) has announced it has submitted a supplemental new drug application (NDA) to the US Food and Drug...
July 31, 2018

ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation

ARCA Biopharma (NASDAQ:ABIO) has announced it has received guidance from the US Food and Drug Administration (FDA) following an End-of-Phase...
July 25, 2018

Corbus Pharmaceuticals to Commence Phase 3 Study of Lenabasum for the Treatment of Rare Autoimmune Disease Dermatomyositis

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) has announced that it will proceed with a Phase 3 trial evaluating the efficacy and safety...